By Joshua Nubla, PharmD; Neal Dave, PharmD; and Michael Reff, RPh, MBA

An in-depth look into a nationwide collaborative initiative to standardize and improve oncology dispensing practices for the benefit of patient/provider education, adherence, and overall care.

Care for patients in the oncology setting is extremely diverse and complex. Management of the many distinct oral oncolytic regimens through pharmacy dispensing platforms in clinical practice can leave gaps within the healthcare system that should be addressed. These gaps are not caused by knowledge gaps; they result from a lack of contact with consistent and updated education material that succinctly describes and explains the primary details of treatment with specific medications, including but not limited to compliance obstacles and solutions, instructions on managing side effects and major adverse effects, and expectations of therapeutic onset and duration. Read article here.

Read More
A letter from members of the U.S. Congress urging the U.S. Department of Health and Human Services (HHS) and Centers for Medicare & Medicaid Services (CMS) to "work within existing authority to ensure Medicare Part D plan sponsors dedicate a meaningful share of negotiated rebates, discounts, and other fees to reduce Part D patients’ out-of pocket costs for covered medicines at the point-of-sale.”
Read More